Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors
Johanna Theruvath, Elena Sotillo, Christopher Mount, et al.
Nature Medicine (2020) Vol. 26, Iss. 5, pp. 712-719
Open Access | Times Cited: 236

Showing 1-25 of 236 citing articles:

GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas
Robbie G. Majzner, Sneha Ramakrishna, Kristen W. Yeom, et al.
Nature (2022) Vol. 603, Iss. 7903, pp. 934-941
Open Access | Times Cited: 570
Navigating CAR-T cells through the solid-tumour microenvironment
Andrew J. Hou, Laurence C. Chen, Yvonne Y. Chen
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 7, pp. 531-550
Open Access | Times Cited: 370
CAR immune cells: design principles, resistance and the next generation
Louai Labanieh, Crystal L. Mackall
Nature (2023) Vol. 614, Iss. 7949, pp. 635-648
Closed Access | Times Cited: 339
PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial
Vivek Narayan, Julie S. Barber-Rotenberg, In-Young Jung, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 724-734
Open Access | Times Cited: 307
Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours
Christian Flugel, Robbie G. Majzner, Giedre Krenciute, et al.
Nature Reviews Clinical Oncology (2022) Vol. 20, Iss. 1, pp. 49-62
Open Access | Times Cited: 243
Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis
Nicholas A. Vitanza, Adam Johnson, Ashley Wilson, et al.
Nature Medicine (2021) Vol. 27, Iss. 9, pp. 1544-1552
Closed Access | Times Cited: 218
B7-H3/CD276: An Emerging Cancer Immunotherapy
Wu-Tong Zhou, Weilin Jin
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 199
Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety
Nicholas A. Vitanza, Ashley Wilson, Wenjun Huang, et al.
Cancer Discovery (2022) Vol. 13, Iss. 1, pp. 114-131
Open Access | Times Cited: 169
Control of the activity of CAR-T cells within tumours via focused ultrasound
Yiqian Wu, Yahan Liu, Ziliang Huang, et al.
Nature Biomedical Engineering (2021) Vol. 5, Iss. 11, pp. 1336-1347
Open Access | Times Cited: 143
Next-Generation CAR T-cell Therapies
Regina M. Young, Nils W. Engel, Uğur Uslu, et al.
Cancer Discovery (2022) Vol. 12, Iss. 7, pp. 1625-1633
Open Access | Times Cited: 125
FUT8-mediated aberrant N-glycosylation of B7H3 suppresses the immune response in triple-negative breast cancer
Yun Huang, Hailiang Zhang, Zhi‐Ling Li, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 119
CAR T Cell-Based Immunotherapy for the Treatment of Glioblastoma
Luke Maggs, Giulia Cattaneo, Ali Emre Dal, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 114
GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicity
Sabine Heitzeneder, Kristopher R. Bosse, Zhongyu Zhu, et al.
Cancer Cell (2021) Vol. 40, Iss. 1, pp. 53-69.e9
Open Access | Times Cited: 113
Allogeneic CAR T Cells: An Alternative to Overcome Challenges of CAR T Cell Therapy in Glioblastoma
Darel Martínez Bedoya, Valérie Dutoit, Denis Migliorini
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 111
Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy
Binghao Zhao, Huanzhang Li, Yu Xia, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 111
In vivo imaging of nanoparticle-labeled CAR T cells
Louise Kiru, Aimen Zlitni, Aidan M. Tousley, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 6
Open Access | Times Cited: 83
CAR T Cell Therapy in Primary Brain Tumors: Current Investigations and the Future
Ya-Jui Lin, Leila A. Mashouf, Michael Lim
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 74
Tumor inflammation-associated neurotoxicity
Jasia Mahdi, Jörg Dietrich, Karin Straathof, et al.
Nature Medicine (2023) Vol. 29, Iss. 4, pp. 803-810
Open Access | Times Cited: 63
mTORC1 upregulates B7-H3/CD276 to inhibit antitumor T cells and drive tumor immune evasion
Heng-Jia Liu, Heng Du, Damir Khabibullin, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 47
Adoptive cell therapy for cancer treatment
Shi Du, Jinyue Yan, Yonger Xue, et al.
Exploration (2023) Vol. 3, Iss. 4
Open Access | Times Cited: 47
CRISPR Screening of CAR T Cells and Cancer Stem Cells Reveals Critical Dependencies for Cell-Based Therapies
Dongrui Wang, Briana C. Prager, Ryan C. Gimple, et al.
Cancer Discovery (2020) Vol. 11, Iss. 5, pp. 1192-1211
Open Access | Times Cited: 116
Cell-surface antigen profiling of pediatric brain tumors: B7-H3 is consistently expressed and can be targeted via local or systemic CAR T-cell delivery
Dalia Haydar, Haley Houke, Jason Chiang, et al.
Neuro-Oncology (2020) Vol. 23, Iss. 6, pp. 999-1011
Open Access | Times Cited: 99
Unique challenges for glioblastoma immunotherapy—discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank
Pavlina Chuntova, Frances Chow, Payal Watchmaker, et al.
Neuro-Oncology (2020) Vol. 23, Iss. 3, pp. 356-375
Open Access | Times Cited: 83
The Role of CD276 in Cancers
Shengzhuo Liu, Jiayu Liang, Zhihong Liu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 82
Diffuse intrinsic pontine glioma: current insights and future directions
Dilakshan Srikanthan, Michael S. Taccone, Randy Van Ommeren, et al.
Chinese Neurosurgical Journal (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 57
Page 1 - Next Page

Scroll to top